B- and T-cell Ontogeny

Last updated: November 12, 2024
  • Describe the B cell developmental stages
    • Haematopoietic or Pluripotent stem cell (HSC):
      • Can divide into any lineage
    • Common lymphoid progenitor cell:
      • Multipotent, can differentiate into B or T-cell ****
    • B progenitor cell (pre-pro-B cell):
      • ****Earliest recognizable stage, no heavy chain, no light chain
    • Pro-B cell:
      • D to J rearrangement (early) and V to DJ rearrangement (Late) of the IgH chain gene via RAG1 and RAG2
      • Germline IgL chain gene
      • No Ig protein
      • IL-3, IL-7, IGF-1, SCF are required for growth
      • Express: Pax-5, CD19, HLA-DR, CD34
    • Large Pre-B cell:
      • V to DJ rearrangement of IgH chain gene
      • Germline IgL chain gene
      • pre-BCR
      • Stage implicated in X-linked (Bruton) agammaglobuliemia
    • Small Pre-Bcell:
      • VDJ rearranged IgH chain gene, ****
      • V to J rearrangement of IgL chain gene,
      • Intracellular $\mu$ receptor
      • Express: CD79a, CD10, CD20, CD22, TdT
    • Immature B cell:
      • VDJ rearranged IgH chain gene
      • VJ rearranged IgL chain gene
      • IgM protein on the cell surface
      • Locate in the Bone Marrow (BM)
      • Negative selection occurs at this stage
      • Express: HLA-DR, CD19, CD20, CD40
      • Stops expressing CD10, CD34, RAG1, RAG2, TdT
    • Mature naive B cell:
      • VDJ rearranged IgH chain gene
      • VJ rearranged IgL chain gene
      • IgM and IgD on the cell surface
      • Located in the spleen and secondary lymphatic organs
      • Express: surface IgM, IgD, CD19, CD20
    • Antigen-activated B cell (Plasma cells and memory B cells):
      • ****Undergoes somatic hypermutation and class switching after antigen exposure
      • Long-lived cells from lymph follicles are found in the BM
      • Short lived cells are non-follicular
      • Express: Bcl-6, Pax, CD19, CD20
      • Described as: CD38+, CD138+
  • Briefly describe Positive and Negative selection as it occurs in T-cells
    • T-cell precursor: Committed to T-cell lineage, Migrates to the thymus, does not express surface proteins
    • Double negative stage (Pre-TCR): Somatic recombination of Beta TCR chain, proliferate, express pre-TCR on surface, express CD3
    • Double positive stage: Somatic recombination of alpha TCR chain, Positive selection at cortex, express CD4, CD8, TCR
    • Single positive: Migrate to the medulla of thymus, Negative selection against self antigen,
    • Mature T-cell: Exit into blood stream and migrate btw peripheral tissue, blood vessels and secondary lymphoid organs, to await peripheral activation, Express TCR, either CD4 or CD8
  • Describe negative selection as it occurs in B cells
    • Immature B cell stage
      • IgH chain genes have already undergone VDJ recombination and the IgL gene has undergone VJ recombination
    • IgM is expressed on the cell surface
    • If IgM interacts strongly with membrane bound self-antigens (such as those bound on MHC), the B-cell undergoes:
      • Apoptosis OR,
      • Receptor editing
    • This prevents the formation of self-reacting B-cells
  • Briefly describe somatic hypermutation and antibody class switching
    • Somatic hypermutation
      • Occurs during subsequent antigen exposures to contribute towards affinity maturation, Point mutations that create random alterations in the variable region of the antibody gene, mediated by activation-induced cytosine deaminase (AID) and uracil nucleoside glycosylase (UNG), allows error prone DNA polymerase to introduce mutations
    • Isotype (class) switching
      • Activated B cells within germinal centres change the antibody isotype in response to cytokines secreted by T-cells, antibody gets different function but same affinity,
      • Mediated by switch recombinase
      • First signal is by Antigen presentation by MHCII to TCR of Th cell, Secondary costimulatory signal by CD40 and CD40L,
        • IL-4 and IL-13 for IgE,
        • IL-5, TGFB for IgA,
        • IL-6 for IgM,
        • IFNy, IL-4, IL-21 for IgG
  • Outline the clinical applications of B and T cell ontogeny
    • Determines antibody response to antigens (T dependent and T-independent response)
    • Structural organization of Lymph nodes (Follicles + Germinal centres have B-cells, Cortex mainly composed of T-cell)
    • Central tolerance in B and T cells (negative selection)
    • Congenital immunodeficiencies involving T and B cells (Bruton’s agammaglobulinemia, DiGeorge syndrome)
    • WHO classification of haematological malignancies (AML, ALL, CML, CLL)
    • Diagnosis of lymphomas by flow cytometry (B-cell CD10, CD19, CD20; T-cell CD3, CD5, CD7)

Differentiate between somatic recombination and somatic hypermutation

Somatic recombinationSomatic hypermutation
DefinitionRandom combination of heavy chain gene segmentsRandom mutations introduced into the gene segments coding for the variable region of T and B cell receptors
StimulusAntigen presentation to T-cell receptor via MHC + Cytokine productionAntigen binding
Affinity maturationNoYes
Class switchingYesNo
  • Briefly describe the subsequent stages that follow after immature B cells leave the bone marrow up to antibody generation (write B cell activation in detail)
    • Mature naive B cell:
      • VDJ rearranged IgH chain gene, VJ rearranged IgL chain gene, IgM and IgD on surface, Located in the spleen and secondary lymphatic organs, Express surface IgM, IgD, CD19, CD20
    • B cell activation
      • Exposure to antigen or polyclonal mitogens causes activation and proliferation
      • T dependent or T-independent activation causes the B-cell to undergo Somatic hypermutaion, Class switching and Affinity maturation
      • Memory B cell and Plasma cells are formed
      • Interaction (In-detail)
    • Plasma cell
      • Secrete antibodies
      • Long lived from follicles
      • short lived cells are non-follicular,
      • Express: Bcl-6, Pax-5, CD19, CD20 positive
      • Described as CD39, CD138 positive
    • Memory B cell
      • Identical to resting mature B cell
      • More sensitive to antigen stimulation,
      • Produce high affinity antibodies and persist for many years
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *